Moderna’s CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build a “quantum-ready workforce.”
Moderna’s CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build a “quantum-ready workforce.”